497
Views
20
CrossRef citations to date
0
Altmetric
Editorial

Targeted TGF-β chemotherapies: friend or foe in treating human malignancies?

Pages 609-611 | Published online: 10 Jan 2014
 

Acknowledgements

Members of the Schiemann Laboratory are thanked for critical comments and reading of the manuscript. William P Schiemann is supported by grants from the National Institutes of Health (CA095519 and CA114039), the University of Colorado Cancer Center and the Cancer League of Colorado.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.